Skip to Content Facebook Feature Image

Mobileum Showcases “Signal to Value” at MWC Barcelona 2026

News

Mobileum Showcases “Signal to Value” at MWC Barcelona 2026
News

News

Mobileum Showcases “Signal to Value” at MWC Barcelona 2026

2026-03-17 16:00 Last Updated At:16:20

CUPERTINO, Calif.--(BUSINESS WIRE)--Mar 17, 2026--

Mobileum Inc. (“Mobileum”), a leading global provider of analytics and network solutions, highlighted its ” Signal to Value ” vision at MWC Barcelona 2026, demonstrating how telecom operators can turn network events into insight, action, and revenue.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260317260292/en/

At the event, Mobileum demonstrated how operators can leverage its Active Intelligence Platform to enhance roaming performance, strengthen fraud and risk defenses, and automate network assurance across increasingly complex global networks.

“Operators generate massive volumes of network events every second, but the real value comes from turning those events into insights, action, and revenue,” said Bernardo Lucas, Chief Marketing & Strategy Officer at Mobileum. “At MWC 2026, Mobileum demonstrated how AI and automation can help operators move from raw telecom data to real business impact – whether that means accelerating roaming revenues, protecting networks from emerging fraud threats, or enabling new enterprise services.”

Among the solutions Mobileum showcased were technologies designed to help operators translate network intelligence into measurable business value, including:

Through interactive demo stations, Mobileum demonstrated how operators can turn telecom data into real operational and commercial value across three key areas:

Roaming Reimagined

Mobileum showcased how AI-powered roaming intelligence helps operators improve service quality, optimize partnerships, and unlock new roaming revenue opportunities. Innovations included Mobileum’s Roaming Exposure Function (REF), which provides secure real-time access to roaming intelligence via a standardized, policy-driven API framework, enabling new use cases across fraud mitigation, IoT lifecycle management, customer experience, and analytics. Additional demonstrations featured Roaming DNA, Network Traffic Redirection (NTR), and AI-driven analytics that allow operators to proactively monitor roaming performance, optimize steering strategies, and resolve network issues before they impact subscribers.

Agentic Fraud Defense

Mobileum also highlighted the evolution of its RAID 9 Integrated Risk Management (IRM) platform with the addition of Agentic AI, enabling risk teams to detect threats faster and automate responses while maintaining full operational control. The solution uses AI agents capable of reasoning through fraud and revenue assurance scenarios using telecom industry context, helping risk teams identify emerging threats, prioritize investigations, and automate routine processes. Complementary capabilities demonstrated at MWC included voice security technologies such as Audio Printing and VoiceShield, along with tools like URL Scanner, providing operators with real-time Voice and SMS protection against increasingly sophisticated scam, fraud and security threats

Autonomous Network Assurance

Mobileum showcased how AI-driven automation is transforming network assurance, enabling operators to monitor and optimize complex multi-generation networks more efficiently. Demonstrations included smartphone-based testing for GlobalRoamer®, GenAI-based Root Cause Analysis automation and new probe solutions designed for special environments like hard to reach locations for satellite communications testing. Mobileum also demonstrated advanced functionality for its lab and performance testing solution, dsTest, including automated signaling firewall complex rules validation, and advanced 5G end-to-end call flow analysis, providing deeper visibility into network performance and customer experience across global connectivity environments.

Mobileum also reinforced its support for large-scale global events with the release of its 2026 FIFA World Cup Testing Package, which will provide telecom operators enhanced testing and monitoring tools to validate roaming readiness and maintain service quality during periods of heavy network demand.

Monetizing AI for Enterprise Customers

Mobileum also demonstrated its white-labeled AI Assistant platform, developed in partnership with NOHOLD, which enables telecom operators to offer branded AI assistant services to small and medium-sized enterprises (SMEs). The platform allows operators to deliver subscription-based AI assistants that help businesses automate customer support, improve sales engagement, and enhance productivity, creating new opportunities to monetize AI services through existing enterprise channels.

Together, these advancements reflect Mobileum’s broader Signal to Value vision: helping telecom operators turn network events into trusted intelligence that drives smarter decisions, stronger networks, enhanced operational automation, and new revenue opportunities.

To learn more about the solutions showcased at MWC 2026, book a meeting with our experts by visiting our website.

About Mobileum Inc.

Mobileum is a leading provider of Telecom analytics solutions for roaming, core network, security, risk management, domestic and international connectivity testing, and customer intelligence. More than 1,000 customers rely on its Active Intelligence platform, which provides advanced analytics solutions, allowing customers to connect deep network and operational intelligence with real-time actions that increase revenue, improve customer experience, and reduce costs. Headquartered in Silicon Valley, Mobileum has global offices in Australia, Germany, Greece, India, Japan, Portugal, Singapore, UK, and United Arab Emirates. Learn more at www.mobileum.com

Mobileum team at MWC Barcelona 2026.

Mobileum team at MWC Barcelona 2026.

CAMBRIDGE, England--(BUSINESS WIRE)--Mar 17, 2026--

Alchemab Therapeutics has appointed Ulrich Wendt, PhD MBA, as Chief Business Officer (CBO) to expand partnerships with biopharma for the development of novel antibody therapeutics. As a proven dealmaker and strategist, Dr Wendt brings more than a decade of experience in delivering high-value partnerships across all pipeline stages.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260317585022/en/

Before joining Alchemab, he served as Global Head of Business Development Immunology at Sanofi. Prior to this, Dr Wendt drove global Business Development for Sanofi’s diabetes and primary care business units, and oversaw global search & evaluation and alliance management teams in cardiometabolic disease.

His appointment builds on Alchemab’s recent pharma licensing deals, Series A funding extension, and progression of their first asset into clinical trials.

“As CBO, Ulrich will lead Alchemab's business development and alliance management, working closely with the executive team to expand the company’s partnerships across biopharma and adjacent sectors,” said Jane Osbourn, CEO and Co-Founder of Alchemab. “He will also help guide our corporate strategy as we continue scaling our AI-enabled platform capabilities.”

With academic roots in biostructure and biophysics, Dr Wendt earned his PhD from Freiburg University, completed postdoctoral training at UC Berkeley and Genentech, and gained an MBA from IMD, Lausanne.

"Alchemab's discovery platform positions the company at the intersection of experimental and AI-enabled discovery," Dr Wendt said. "Within the last two years the company has advanced into clinical trials and delivered a stream of preclinical candidates with novel target biology. I am excited to be joining Jane and the Alchemab team at this pivotal time to help position the company for the next wave of growth."

Alchemab is a biotechnology company uncovering the immune secrets of disease-resilient individuals to discover and develop novel antibody therapeutics. Their first asset entered clinical trials in 2025 as part of a licensing deal with Lilly.

The company’s platform integrates the world's largest antibody database derived from disease-resilient individuals with a proprietary AI-powered antibody search engine designed to identify the antibodies that protect them. By pioneering this approach, Alchemab has generated a broad pipeline of treatments for hard-to-treat diseases that could not have been discovered with traditional methods.

For more information, visit alchemab.com

Dr Ulrich Wendt has been appointed Chief Business Officer at Alchemab Therapeutics

Dr Ulrich Wendt has been appointed Chief Business Officer at Alchemab Therapeutics

Recommended Articles